TrialNeuro-oncology2005

Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.

Stuart A Grossman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.